Landing Point Financial Group, LLC
Position in FDMT — 4D Molecular Therapeutics, Inc.
CIK 2025964
AVON, OH
Position in FDMT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$246,050
+$69,160 QoQ
Shares Held
18,500
-2.6% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#97
of 158 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Landing Point Financial Group, LLC holds $464,289 across 2 Biotechnology names. FDMT ranks #1 (53.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FDMT |
4D Molecular Therapeutics, Inc.
This page
|
18,500 | $246,050 | |
| 2 | RGNX |
REGENXBIO Inc.
|
18,217 | $218,239 |
All Filings in FDMT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $246,050 | 18,500 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $176,890 | 19,000 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $142,500 | 19,000 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||